Indacaterol(in da ka’ ter ol)
Arcapta Neohaler
PREGNANCY CATEGORY C
Drug Classes
Beta2 agonist, long-acting
Bronchodilator
Therapeutic Actions
Long-acting agonist that binds to beta2 receptors in the lungs, causing bronchodilation; may also inhibit the release of inflammatory mediators in the lungs, blocking swelling and inflammation.
Indications
-
Long-term maintenance for treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema
Contraindications and Cautions
-
Contraindicated with history of serious hypersensitivity reactions to indacaterol, asthma, deteriorating COPD.
-
Use cautiously with convulsive disorders, thyrotoxicosis, CV disorders, known sensitivity to sympathomimetics, pregnancy, lactation.
Available Forms
Inhalation powder—75 mcg
Dosages
Adults
75 mcg/day by oral inhalation using the Neohaler only.
Pediatric patients
Not recommended.
Pharmacokinetics
|
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
